🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Frank T. Zenke

Merck KGaA, Darmstadt (Germany)

ORCID: 0000-0002-2226-3755

Also affiliated with NBE Therapeutics (Switzerland)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents”.

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-1026

N/A

2.9DataRank · unranked

111 citations

Ilya S. Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim +8 more

ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer

EMBO Molecular Medicine(2023)10.15252/emmm.202217313

N/A

0.944DataRank · unranked

28 citations

Yang Zhang, Rajaâ El Meskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai +21 more

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Cancer Cell(2021)10.1016/j.ccell.2021.02.014

N/A

0DataRank · unranked

178 citations

Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli +36 more

DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia

Scientific Reports(2021)10.1038/s41598-021-90500-3

N/A

0DataRank · unranked

33 citations

Yuki Nishida, Michael I. Carr, Rafael Heinz Montoya, Lauren B. Ostermann, Weiguo Zhang +5 more

Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0998

N/A

0DataRank · unranked

12 citations

Jan Novotný, D. Gulhan, Isabella Klooster, Antuan V. Tran, Macy Kasbo +17 more

The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0402

N/A

0DataRank · unranked

24 citations

Yasuhiro Arakawa, Astrid Zimmermann, Daiki Taniyama, Makito Mizunuma, Lisa M. Jenkins +6 more